Altium Wealth Management LLC Biogen Inc. Transaction History

Altium Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$236.26 - $355.63 $211,452 - $318,288	-895 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $11,385 - $13,145	-43 Reduced 4.58%	895 $254,000
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $42,937 - $56,863	166 Added 21.5%	938 $251,000
Q1 2020 Apr 23, 2020	BUY	$268.85 - $341.04 $207,552 - $263,282	772 New	772 $244,000
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $228,938 - $252,355	-1,044 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$216.71 - $338.96 $2,817 - $4,406	-13 Reduced 1.23%	1,044 $247,000
Q4 2018 Jan 18, 2019	BUY	$278.5 - $352.75 $61,827 - $78,310	222 Added 26.59%	1,057 $318,000
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $245,080 - $320,498	835 New	835 $295,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Altium Wealth Management LLC with notifications on news.